Santosh Shetty

So, just wanted to ask a couple of questions. Like the first one is the hospital has now crossed multiple clinical milestones and oncology appears to be ramping up well. Do you foresee Agartala emerging as one of the highest growth hospitals within the net work over the next 2 or 3 years?

Okay. And another question in regards to that. Howrah has consistently seen improving occupancy. So, what do you think are the key bottlenecks today to increase the occupancy to the fullest? Is it doctor addition, specialty mix or simply market awareness?

Okay, sir. And just the last question. You highlighted increasing inflows from Bangladesh and strong traction in oncology. Could you comment on whether international patient inflows have now normalized to pre-disruption levels? Or is it still further upside over the coming quarters?